LRMR Larimar Therapeutics, Inc.
$2.39▲ +6.70%
Healthcare
Other
After hours
$2.46▲ +2.93%
Oct 27, 5:37 PM ET
Volume 1.20M
Avg Volume (10D) 2.15M
Key Metrics & Fundamentals
Market Cap
$248.28M
P/E Ratio
–
Div Yield
0.00%
52W Range
1.92 - 6.42
% vs 50 MA
-27.79%
% vs 200 MA
-37.43%
RSI-14
39.8
MACD Histogram
+0.0500
Beta (1Y vs SPY)
1.59
Free Cash Flow
-$44.16M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$34.29M
COGS
–
Operating Exp
$34.35M
Operating Income
-$34.35M
EBIT
-$34.35M
Pretax Income
-$32.78M
Net Income
-$32.78M
EPS (Diluted)
-0.30
Price & Volume History
Loading chart…
Recent News

3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Ahead
MarketBeat · Oct 10, 2026 10:35 AM ET

Larimar (LRMR) Loses 22.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Zacks · Oct 5, 2026 8:35 AM ET
Larimar Therapeutics Names John Harlow COO
MT Newswires · Sep 29, 2026 4:27 PM ET

Larimar Therapeutics Strengthens Executive Leadership with Appointment of John Harlow as President and Chief Operating Officer
GlobeNewswire · Sep 29, 2026 4:05 PM ET

5 Small Drug Stocks Poised to Benefit From a Biotech Recovery
Zacks · Sep 14, 2026 9:30 AM ET

Century Therapeutics Appoints Joseph Truitt to Board of Directors
GlobeNewswire · Sep 9, 2026 4:05 PM ET
Larimar: Q2 Earnings Snapshot
Associated Press · Aug 4, 2026 7:09 AM ET
Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update
GlobeNewswire · Aug 4, 2026 7:00 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See LRMR's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.